Sports Medicine & Spine Rehab Pc Hempstead, NY - 11550

Sports Medicine & Spine Rehab Pc is categorized under Sports Medicines in Hempstead, NY and active since 2009.

Sports Medicine & Spine Rehab Pc was established in 2009, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Sports Medicines business, which does work in the B2C market, and is classified as a Sports Medicines, under code number 621111 by the NAICS.

If you are seeking more information, feel free to contact Joseph G Gregorace at the company’s single location by writing to 44 Angevine Avenue, Hempstead, New York NY 11550 or by phoning (516) 485-5060. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Sports Medicine & Spine Rehab Pc
Contact Person: Joseph G Gregorace
Address: 44 Angevine Avenue, Hempstead, New York 11550
Phone Number: (516) 485-5060
Annual Revenue (USD): $100.000 to $499.999
Founded: 2009
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Sports Medicines
SIC Code: 8011
NAICS Code: 621111
Share This Business:

Sports Medicine & Spine Rehab Pc was started in 2009 to provide professional Sports Medicines under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Joseph G Gregorace for inquiries that concern Sports Medicine & Spine Rehab Pc by calling the company number (516) 485-5060, as your correspondence is most welcome. Additionally, the physical location of the single location of Sports Medicine & Spine Rehab Pc can be found at the coordinates 40.701334,-73.620107 as well as the street address 44 Angevine Avenue in Hempstead, New York 11550.

For its online presence, you may visit Sports Medicine & Spine Rehab Pc’s website at and engage with its social media outlets through on Twitter and on Facebook.